Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 1/20 | 0.46 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.46 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.46 |
| ▸ | ENGASE | Q8NFI3 | 1/20 | 0.44 |
| ▸ | CD209 | Q9NNX6 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | AMY2A | P04746 | 3/20 | 0.41 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | TYR | P14679 | 6/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12601230 | 0.94 | LGALS8 (0.42) | LGALS8LGALS3LGALS4ENGASECD209 | |
| SCHEMBL17637024 | 0.92 | LGALS8 (0.41) | LGALS8LGALS3LGALS4ENGASECD209 | |
| SCHEMBL824856 | 0.92 | L3MBTL1 (0.48) | LGALS8LGALS3LGALS4L3MBTL1AMY2A | |
| SCHEMBL17298260 | 0.89 | TYR (0.42) | LGALS8LGALS3LGALS4ENGASECD209 | |
| SCHEMBL17833867 | 0.89 | LGALS8 (0.46) | LGALS8LGALS3LGALS4ENGASECD209 | |
| SCHEMBL12995245 | 0.88 | LGALS8 (0.38) | LGALS8LGALS3LGALS4ENGASECD209 | |
| SCHEMBL24004413 | 0.86 | L3MBTL1 (0.53) | LGALS8LGALS3LGALS4L3MBTL1AMY2A | |
| SCHEMBL13034058 | 0.86 | L3MBTL1 (0.53) | LGALS8LGALS3LGALS4L3MBTL1AMY2A | |
| SCHEMBL24004411 | 0.86 | L3MBTL1 (0.53) | LGALS8LGALS3LGALS4L3MBTL1AMY2A | |
| SCHEMBL20998700 | 0.85 | L3MBTL1 (0.57) | LGALS8LGALS3LGALS4L3MBTL1AMY2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9968905-B2 | Processing biomass | XYLECO, INC. (US) | 2018-05-15 | — | — | US | disclosed |
| US-9278896-B1 | Processing biomass | XYLECO, INC. (US) | 2016-03-08 | — | — | US | disclosed |
| US-9187769-B1 | Processing biomass | XYLECO, INC. (US) | 2015-11-17 | — | — | US | disclosed |
| US-20150265997-A1 | PROCESSING BIOMASS | XYLECO, INC. | 2015-09-24 | — | — | US | disclosed |
| US-9132407-B1 | Processing biomass | XYLECO, INC. (US) | 2015-09-15 | — | — | US | disclosed |
| US-9062328-B2 | Processing biomass | XYLECO, INC. (US) | 2015-06-23 | — | — | US | disclosed |
| US-20150104843-A1 | PROCESSING BIOMASS | XYLECO, INC. | 2015-04-16 | — | — | US | disclosed |
| US-8946489-B2 | Processing biomass | XYLECO, INC. (US) | 2015-02-03 | — | — | US | disclosed |
| US-20140329280-A1 | PROCESSING BIOMASS | XYLECO, INC. (US) | 2014-11-06 | — | — | US | disclosed |
| US-8716537-B2 | Processing biomass | XYLECO, INC. (US) | 2014-05-06 | — | — | US | disclosed |
| US-8497366-B2 | Processing biomass | XYLECO, INC. (US) | 2013-07-30 | — | — | US | disclosed |
| US-20130102029-A1 | Processing Biomass | XYLECO, INC. (US) | 2013-04-25 | — | — | US | disclosed |
| US-8212087-B2 | Processing biomass | XYLECO, INC. (US) | 2012-07-03 | — | — | US | disclosed |
| US-8142620-B2 | Processing biomass | XYLECO, INC. (US) | 2012-03-27 | — | — | US | disclosed |
| US-8083906-B2 | Processing biomass | XYLECO, INC. (US) | 2011-12-27 | — | — | US | disclosed |
| US-20100304439-A1 | PROCESSING BIOMASS | XYLECO, INC. (US) | 2010-12-02 | — | — | US | disclosed |
| US-20100179315-A1 | PROCESSING BIOMASS | XYLECO, INC. (US) | 2010-07-15 | — | — | US | disclosed |
| US-20100087687-A1 | PROCESSING BIOMASS | XYLECO, INC. (US) | 2010-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087687-A1 | PROCESSING BIOMASS | GYS2, GYS1, MGAM | LGALS8 419/4885LGALS3 462/4885LGALS4 321/4885 |
| US-20100179315-A1 | PROCESSING BIOMASS | GYS2, GYS1, MGAM | LGALS8 419/4885LGALS3 462/4885LGALS4 321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.